Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients—Focus on Clinical and Histopathological Variation

Background: The most common autoimmune blistering disease, bullous pemphigoid (BP), shows an increased prevalence in psoriatic patients and oncologic patients undergoing immune-checkpoint blockade (ICB). Even though the same autoantigens (BP180/BP230) are detectable, it remains obscure whether clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Niebel, Dennis, Wilsmann-Theis, Dagmar, Bieber, Thomas, Berneburg, Mark, Wenzel, Joerg, Braegelmann, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947168/
https://www.ncbi.nlm.nih.gov/pubmed/35323203
http://dx.doi.org/10.3390/dermatopathology9010010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947168/
https://www.ncbi.nlm.nih.gov/pubmed/35323203
http://dx.doi.org/10.3390/dermatopathology9010010

Ejemplares similares